RxDoctor Payments DataLook up a doctor →

Daniel Rosenberg, MD

Pediatrics · Novi, MINPI 1629038526

Payments from drug & device makers

$13,479in general payments, 2019–2025

Across 622 payments — averaging $21.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • AstraZeneca$712
  • GSK$655
  • Pfizer$616
  • plus $4K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)56$4,325
Novo Nordisk98$1,512
Lilly USA, LLC106$1,374
AstraZeneca34$712
GSK41$655
Pfizer43$616
Boehringer Ingelheim34$596
Takeda Pharmaceuticals U.S.A., Inc.17$255
Novartis14$242
Axsome Therapeutics, Inc.9$240
Amgen15$235
Exact Sciences12$232
Abbott11$222
Merck13$206
Dexcom, Inc.7$146
Amarin Pharma, Inc.7$123
E.r. Squibb & Sons, L.L.C.7$121
Teva Pharmaceuticals USA, Inc.8$115
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$108
Ironshore Pharmaceuticals Inc.6$104
Gilead5$101
Cranial Technologies, Inc6$94
Kowa Pharmaceuticals America, Inc.7$94
Sanofi Pasteur Inc.5$92
Alk-abello, Inc5$90
AMAG Pharmaceuticals, Inc.4$79
Biohaven Pharmaceutical Holding Company Ltd.2$47
IBSA Pharma Inc.3$45
Bioventus LLC2$45
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$40
Idorsia Pharmaceuticals US Inc2$38
Genentech USA, Inc.2$38
Actelion Pharmaceuticals US, Inc.2$35
Esperion Therapeutics, Inc.2$35
Bausch Health US, LLC2$34
Biohaven Pharmaceuticals, Inc.2$32
Otsuka America Pharmaceutical, Inc.2$32
Tactile Systems Technology Inc2$32
Arbor Pharmaceuticals, Inc.2$29
Supernus Pharmaceuticals, Inc.2$26
Johnson & Johnson2$25
Astellas Pharma US Inc1$23
Kyowa Kirin, Inc.1$23
Verrica Pharmaceuticals Inc.1$21
Averitas Pharma Inc.1$20
Boston Scientific1$19
Corium, LLC1$19
Daiichi Sankyo Inc.1$18
Phathom Pharmaceuticals, Inc.1$18
Vivus LLC1$17
Ferring Pharmaceuticals Inc.1$17
Xeris Pharmaceuticals, Inc.1$17
Dynavax Technologies Corporation1$16
Sanofi-aventis U.S. LLC1$14
Tris Pharma Inc1$13
Vivaquant Inc, Dba Rhythm Express1$9

How this compares

$13,479 in reported general payments places this provider in the 95th percentile of 1,473 pediatrics providers in Michigan.

See all pediatrics providers in Michigan

Medicare billing

Part B allowed, 2024
$123,349
Medicare patients
218
Services billed
4,637

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatrics in Novi

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →